SOLIGENIX, INC. — Director's Dealing 2007

Aug 14, 2007

SEC Form 3/A — Form 3/A

Issuer: DOR BIOPHARMA INC (DORB)
CIK: 0000812796
Period of Report: 2006-08-29

Reporting Person: SCHABER CHRISTOPHER J (Director, President and CEO)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (right to buy)	$0.27	2016-08-28	Common Stock (2000000)		Direct

Footnotes

F1: This form was amended to reduce the original 2,500,000 options granted on August 29, 2006, to 2,000,000 options. Under the 2005 Equity Incentive Plan, only 2,000,000 stock options may be authorized in a calendar year. The additional 500,000 stock options will be granted on August 10, 2007. As previously reported 833,333 stock options vest immediately and the remainder vest quarterly on each three (3) month anniversary of the effective date of this form at a rate of 138,890 stock options.